Aytu BioPharma, Inc (AYTU) stock
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026Score 9/3079% below fair value
$1.78−0.01 (-0.56%)
Close on Nov 13, 2026Market cap $19.34MP/E –Yield –
Aytu BioPharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Aytu BioPharma's ebitda for the twelve months ending Jun 30, 2026 was -$4.39M. For fiscal 2026 it was -$4.39M. The highest annual figure on record is $5.13M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$4.39M | – |
| FY2025 | Jun 30, 2025 | -$2.45M | -147.7% |
| FY2024 | Jun 30, 2024 | $5.13M | – |
| FY2023 | Jun 30, 2023 | -$8.25M | – |
| FY2022 | Jun 30, 2022 | -$99.76M | – |
| FY2021 | Jun 30, 2021 | -$49.67M | – |
| FY2020 | Jun 30, 2020 | -$15.42M | – |
| FY2019 | Jun 30, 2019 | -$14.12M | – |
| FY2018 | Jun 30, 2018 | -$17.11M | – |
| FY2017 | Jun 30, 2017 | -$15.76M | – |
| FY2016 | Jun 30, 2016 | -$20.83M | – |
| FY2015 | Jun 30, 2015 | -$7.51M | -126664.2% |
| FY2013 | Aug 31, 2013 | $5.94K | – |
| FY2012 | Aug 31, 2012 | -$2.95K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $344.00K | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.94M | -179.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$1.09M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$701.00K | -273.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$6.16M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.71M | +1464.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$403.00K | -108.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $404.00K | -70.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$715.00K | -131.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $237.00K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $5.05M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $1.36M | +176.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $2.29M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$6.72M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$5.02M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $493.00K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$14.72M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$50.85M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$8.62M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$25.02M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$20.75M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$25.60M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$5.56M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$1.52M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$4.70M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$4.77M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$4.95M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$3.87M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$3.83M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$4.27M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$4.53M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$2.86M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$3.21M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$7.43M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$3.66M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$3.70M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$3.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$4.83M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$4.17M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$5.14M | – |
See a number that looks wrong?